Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析

◆英語タイトル:Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31788FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥53,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nippon Shinyaku Co Ltd (4516) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nippon Shinyaku Co Ltd (Nippon Shinyaku) develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; gastrointestinal disorders; cardiovascular and metabolic diseases among others. Nippon Shinyaku also provides functional food ingredients including health food ingredients, preservatives, spices and condiments, and protein preparations. Its functional food products find application in meat processing, fish processing, dairy product, prepared food, confectionery and bakery, and beverage, among others. The company operates business through a network of offices and research laboratories in Japan, China, the UK and the US. Nippon Shinyaku is headquartered in Minami-ku, Kyoto, Japan.

Nippon Shinyaku Co Ltd Key Recent Developments

Nov 13,2020: The “Moshikashite NMD” project is launched. Special dance and check tools are developed collaboratively to help discover neuromuscular disorders earlier
Jul 01,2020: Nippon Shinyaku : Investment in the newly established Biotech funds
Mar 24,2020: Nippon Shinyaku announces final completion of API manufacturing building
Jan 20,2020: Nippon Shinyaku signed the United Nations Global Compact (UNGC)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nippon Shinyaku Co Ltd – Key Facts
Nippon Shinyaku Co Ltd – Key Employees
Nippon Shinyaku Co Ltd – Key Operational Employees
Nippon Shinyaku Co Ltd – Major Products and Services
Nippon Shinyaku Co Ltd – History
Nippon Shinyaku Co Ltd – Company Statement
Nippon Shinyaku Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nippon Shinyaku Co Ltd – Business Description
Business Segment: Functional Food
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Nippon Shinyaku Co Ltd – Corporate Strategy
Nippon Shinyaku Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nippon Shinyaku Co Ltd – Strengths
Nippon Shinyaku Co Ltd – Weaknesses
Nippon Shinyaku Co Ltd – Opportunities
Nippon Shinyaku Co Ltd – Threats
Nippon Shinyaku Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2020: The “Moshikashite NMD” project is launched. Special dance and check tools are developed collaboratively to help discover neuromuscular disorders earlier
Jul 01, 2020: Nippon Shinyaku : Investment in the newly established Biotech funds
Mar 24, 2020: Nippon Shinyaku announces final completion of API manufacturing building
Jan 20, 2020: Nippon Shinyaku signed the United Nations Global Compact (UNGC)
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nippon Shinyaku Co Ltd, Key Facts
Nippon Shinyaku Co Ltd, Key Employees
Nippon Shinyaku Co Ltd, Key Operational Employees
Nippon Shinyaku Co Ltd, Major Products and Services
Nippon Shinyaku Co Ltd, History
Nippon Shinyaku Co Ltd, Other Locations
Nippon Shinyaku Co Ltd, Subsidiaries
Nippon Shinyaku Co Ltd, Key Competitors
Nippon Shinyaku Co Ltd, Ratios based on current share price
Nippon Shinyaku Co Ltd, Annual Ratios
Nippon Shinyaku Co Ltd, Annual Ratios (Cont...1)
Nippon Shinyaku Co Ltd, Annual Ratios (Cont...2)
Nippon Shinyaku Co Ltd, Interim Ratios
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UOB Private Banking:企業の戦略・SWOT・財務情報
    UOB Private Banking - Strategy, SWOT and Corporate Finance Report Summary UOB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oki Electric Industry Co., Ltd.:企業の戦略・SWOT・財務分析
    Oki Electric Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oki Electric Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Pyxant Labs Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that provides good laboratory practice (GLP) bioanalytical chemistry support and contract research services. The laboratory offers services such as picogram-level bioanalytical method development, analytical and bioanalytical support for …
  • Amgen Inc (AMGN)-医療機器分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • GC Pharma (006280):製薬・医療:M&Aディール及び事業提携情報
    Summary GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and a …
  • China Communications Construction Co Ltd:戦略・SWOT・企業財務分析
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Morgan Advanced Materials plc (MGAM):企業の財務・戦略的SWOT分析
    Summary Morgan Advanced Materials Plc (Morgan) is a diversified company. The company designs, manufactures and markets technical ceramics, thermal ceramics, molten metal systems, electrical carbon, braze alloys, fire protection products, seals and bearings, specialty graphite, and composites and def …
  • Otto Bock HealthCare GmbH-医療機器分野:企業M&A・提携分析
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • Wolfgang Puck Worldwide, Inc.:企業の戦略・SWOT・財務情報
    Wolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kansas Electric Power Cooperative, Inc.:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • UMW Holdings Berhad (UMW):石油・ガス:M&Aディール及び事業提携情報
    Summary UMW Holdings Bhd (UMW) is a diversified company. The company operates through its business divisions such as automotive, equipment, manufacturing and engineering, and oil and gas. Its automotive business manufactures, assembles, markets and distributes passenger cars and commercial vehicles. …
  • California Cryobank-製薬・医療分野:企業M&A・提携分析
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • Swiss International Air Lines Ltd.:企業の戦略・SWOT・財務情報
    Swiss International Air Lines Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swiss International Air Lines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nan Ya Plastics Corporation:企業の戦略・SWOT・財務分析
    Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report Summary Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • John Wood Group Plc (WG.):企業の財務・戦略的SWOT分析
    John Wood Group Plc (WG.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Inspire Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Inspire Medical Systems Inc (Inspire) is a medical device company that manufactures and markets healthcare implants. The company provides implanted neurostimulation device. Its product is used for treatment of obstructive sleep apnea. Inspire uses neurostimulation technologies. The company’s …
  • Codere S.A.:企業の戦略・SWOT・財務情報
    Codere S.A. - Strategy, SWOT and Corporate Finance Report Summary Codere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Translate Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆